Researchers now plan to investigate the optimal dose schedule for injection of the virus.
研究者目前正测试该病毒注射的最佳剂量方案。
Further studies are needed for optimal dose schedule and remote effect of ACR in the treatment of ML.
对于ACR治疗淋巴瘤的合适剂量方案及远期作用尚需进一步研究。
Results It was found that the rate of recipients with non- compliance was 28.3%. They are characterized with changing the drug dose or schedule and putting off checking-up.
结果28．3%的患者没有完全依从治疗计划，主要表现为没有定时、定量服药及没有及时复诊。
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia.
替匹法尼用一周，停一周剂量递增治疗复发性，难治性或高危髓细胞性白血病1阶段试验。
A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia.
替匹法尼用一周，停一周剂量递增治疗复发性，难治性或高危髓细胞性白血病1阶段试验。
应用推荐